Board MeetingBoard Meeting
Kwality Pharma (KPL) reports strong Q1 FY27. Revenue rose 46% YoY to ₹162 Cr, and PAT surged 119% to ₹26 Cr.
Kwality Pharmaceuticals Ltd539997 · Filed with the exchange
Management upgraded FY27 guidance: Revenue ₹700+ Cr, PAT ₹109+ Cr.
R&D is advancing with 13 BE studies completed and new product registrations.
No comments yet. Be the first.